Potential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies. (Q33818302)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21312073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

review article

1 reference

title

Potential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21312073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21312073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

6

Elizabeth Delzell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21312073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

5

Kenneth G Saag

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21312073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Jie Zhang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21312073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Huifeng Yun

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21312073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Meredith Kilgore

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21312073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

1 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21312073%20AND%20SRC:MED&resulttype=core&format=json

Current Rheumatology Reports

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21312073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21312073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21312073%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

273-282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21312073%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11926-011-0168-8

22 January 2020

exact match

0 references

cites work

The societal burden of osteoporosis

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Fragility fractures of the hip and femur: incidence and patient characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Exposure to oral bisphosphonates and risk of esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Developments in post-marketing comparative effectiveness research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Congress responds to the IOM drug safety report--in full.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

A review of uses of health care utilization databases for epidemiologic research on therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Primer: administrative health databases in observational studies of drug effects--advantages and disadvantages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Medicare part D data: major changes on the horizon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Estimated prevalence and patterns of presumed osteoporosis among older Americans based on Medicare data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

The complex relation between bisphosphonate adherence and fracture reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Immeasurable time bias in observational studies of drug effects on mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Methods to examine the impact of compliance to osteoporosis pharmacotherapy on fracture risk: systematic review and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Methods for evaluation of medication adherence and persistence using automated databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Validity of a prescription claims database to estimate medication adherence in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Linking the Iowa Women's Health Study cohort to Medicare data: linkage results and application to hip fracture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Linking Centers for Medicare & Medicaid Services data with prospective DCOR trial data: methods and data comparison results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Development of a comorbidity index using physician claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Improved comorbidity adjustment for predicting mortality in Medicare populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Use of disease risk scores in pharmacoepidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Oral erythromycin and the risk of sudden death from cardiac causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Adaptation of Bayesian data mining algorithms to longitudinal claims data: coxib safety as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

The central role of the propensity score in observational studies for causal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Abstracts from the 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-011-0168-8

Oral bisphosphonate prescriptions and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus

21 January 2018

1 reference

12 December 2020

Four-dollar generics--increased accessibility, impaired quality assurance

1 reference

12 December 2020

Medication compliance and persistence: terminology and definitions

1 reference

12 December 2020

A computer program for incidence density sampling of controls in case-control studies nested within occupational cohort studies.

1 reference

12 December 2020

Clinical and demographic factors associated with fractures among older Americans

1 reference

12 December 2020

Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis

1 reference

12 December 2020

Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort

1 reference

12 December 2020

When are observational studies as credible as randomised trials?

1 reference

12 December 2020